Back to
The UK-hosted Global Vaccine Summit heralds a new era of global health collaboration as world leaders show overwhelming commitment to equitable immunisation coverage and global health security in the face of the COVID-19 pandemic.
World leaders make historic commitments to provide equal access to vaccines for all
Global Vaccine Summit - 4 June 2020
Pledging announcements
On the eve of the Global Vaccine Summit 2020, five manufacturers commit to increasing and prioritising HPV vaccine supply to Gavi-supported countries, which have among the highest cervical cancer burdens in the world.
Private sector partners strengthen Gavi programmes with more than US$ 70 million in contributions
The commitments build on the potency of public private partnerships, which have contributed to Gavi’s success.
Switzerland commits CHF 30 million to Gavi
Contribution will go towards Gavi’s efforts to deliver life-saving vaccines to children in the world’s poorest countries in 2021-2025 strategic period.
Italy deepens support for Gavi with €150 million IFFIm pledge
Pledge follows €120 million in direct funding to Gavi Italy announced at last month’s Coronavirus Global Response pledging conference.
Gavi receives US$ 5 million from The Rockefeller Foundation
Gavi receives US$ 5 million from the Rockefeller Foundation to support health workers facing COVID-19 pandemic
The UPS Foundation commits US$ 3 million to Gavi
UPS partnership with Gavi builds on successful efforts to expand and improve vaccine delivery in Uganda and some of the world’s most underserved communities.
New donor Greece pledges €1.5 million to Gavi COVID response
New funding for Gavi to support lower-income countries’ response to the COVID-19 pandemic, including supporting health systems.
New Zealand announces NZ$ 7 million pledge to Vaccine Alliance
Funding will support the response to the COVID-19 pandemic in lower-income countries as well as the vaccination of thousands of children in vulnerable Pacific nations.
Canada commits CAD 600 million to Gavi
Canada’s contribution will go towards Gavi’s efforts to deliver life-saving vaccines to children in the world’s poorest countries in 2021-2025 strategic period.
Spain pledges new support to Gavi
Funding will help immunise 300 million children over the next five years, saving up to 8 million lives, as well as support universal access to COVID-19 vaccines.
Italy pledges new support to Gavi
Funding will help immunise 300 million children over the next five years, saving up to 8 million lives, as well as support universal access to COVID-19 vaccines.
Countries pledge new support to Gavi
The funding will help immunise 300 million children over the next five years, saving up to 8 million lives, as well as support universal access to COVID-19 vaccines.
Norway increases commitment to immunisation for the most vulnerable, pledges USD 1 billion to Gavi
Funding will help Gavi protect the most vulnerable, particularly children, against a range of infectious diseases.
Gavi welcomes UK funding pledge
Funding will support Gavi’s response to COVID-19 along with efforts to vaccinate 300 million children across the developing world, saving up to 8 million lives.
Gavi welcomes US$ 10 million contribution from TikTok
Short video platform pledges to support Gavi’s life-saving immunisation programmes and future deployment of COVID-19 vaccines.
Saudi Arabia pledges US$ 150 million to Gavi COVID response
Pledge follows G20 commitment to provide immediate resources to Gavi.
Reed Hastings and Patty Quillin support Gavi with US$ 30 million donation
Cash donation supports the Alliance’s response to COVID-19 and helps protect the world against new outbreaks of other infectious diseases.
Messages of support
Gavi champions and voices of support
Load more
Global Vaccine Summit 2020
2020 marks an important milestone for Gavi to build on the historic gains made since its creation, 20 years ago. This meeting will bring together global leaders from the public and private sectors.
Read more
It follows Gavi’s second successful pledging conference in Berlin hosted in January 2015 by Chancellor Angela Markel under the auspices of Germany’s G7 Presidency, which raised US$ 7.5 billion for the 2016-2020 period.
The UK and Gavi
The UK is one of Gavi’s six original donors and one of two donor countries that support Gavi through all three funding channels (direct grants, IFFIm and AMC).
For the 2000-2020 period, the UK has committed USD 3 billion in direct funding (2000-2020), of which USD 61 million (GBP 50 million) is allocated to the Matching Fund (2011-2015). Moreover, the UK has pledged USD 2.7 billion in IFFIm (for 2007-2029), USD 485 million to the pneumococcal AMC (for 2010-2018) and USD 40 million to IPV (for 2013-2018).
In 2011, Prime Minister David Cameron hosted Gavi’s donor pledging conference in London.
The 2021-2025 Investment Opportunity
Gavi's Investment Opportunity was launched at a high-level meeting hosted by the Government of Japan on the occasion of the 7th Tokyo International Conference on African Development (TICAD) in Yokohama on 30 August 2019. Prime Minister Abe announced Gavi’s Investment Opportunity launch in his opening speech at TICAD.
Read more
The Investment Opportunity highlighted that more children have been immunised with a wider range of vaccines than at any time in history. With support from Gavi’s partners and bold commitments from donors, implementing countries and the private sector, the Alliance is poised to bring about even greater impact in the coming five years. Through its innovative approach to development, including innovative finance, the Alliance will help countries PREVENT disease with vaccines in order to PROTECT the next generation and ensure countries can PROSPER. By working together, and with enough support, we can achieve more impact, more efficiently and at a lower cost to donors than ever before.
With countries squarely in the driving seat, Gavi will help foster long-term sustainability and vaccine supply security through its unique transition model and market shaping efforts. Our work together – leveraging donor financing, empowering countries, shaping sustainable markets – will:
- Allow us to achieve the Alliance’s goals and reach a further 300 million children between 2021 and 2025 and, through the full protection of the broadest vaccine portfolio in history, save an additional 7–8 million lives.
- Catalyse country contributions of US$ 3.6 billion in domestic co-financing and self-funded vaccine programmes.
- Contribute to a further US$ 80–100 billion in economic benefits.
- Enhance the competitiveness and supply security of at least five Gavi-supported vaccine markets.
In order to deliver on its ambitious plans and deliver the most comprehensive package of protection in Alliance history, Gavi will need at least US$ 7.4 billion in additional resources for the period 2021–2025.
With countries squarely in the driving seat, Gavi will help foster long-term sustainability and vaccine supply security through its unique transition model and market shaping efforts. Our work together – leveraging donor financing, empowering countries, shaping sustainable markets – will:
- Allow us to achieve the Alliance’s goals and reach a further 300 million children between 2021 and 2025 and, through the full protection of the broadest vaccine portfolio in history, save an additional 7–8 million lives.
- Catalyse country contributions of US$ 3.6 billion in domestic co-financing and self-funded vaccine programmes.
- Contribute to a further US$ 80–100 billion in economic benefits.
- Enhance the competitiveness and supply security of at least five Gavi-supported vaccine markets.
Pivotal moment
This ambitious programme is realistic and within reach. Without critical funding however, we run the risk of losing the momentum of our hard-fought gains and even backsliding.
The next strategic period will be a critical one for Gavi and represents a turning point in our history. With the political will and investment of countries, the ingenuity of Alliance partners, and the generosity of its donors, we can achieve a world where we can make vaccines work for all.
Prevent, Protect, Prosper
This is the time to build on the unprecedented gains from Gavi’s past investments and historical achievements to bring about continued acceleration of immunisation.
Its collaborative model brings the best resources in global health and immunisation together and can continue to use innovation to achieve even stronger impact. Now is not the time for complacency. Now is the time for renewed commitment to help countries prevent disease, protect their communities and, above all, prosper.
Featured content
Scientists around the world are working faster than ever to develop and produce vaccines that can stop the spread of COVID-19, with 21 vaccines now being rolled out in countries worldwide. Here is an at-a-glance overview of those vaccines and…
Five ways that scientists are ensuring the safety of COVID-19 vaccines
As companies race to develop COVID-19 vaccines, some development processes have been run in parallel to stop the pandemic as quickly as possible. Yet safety remains paramount; now that we are on the brink of rolling out some of the vaccines that…
Why handwashing with soap is the most effective way to stop viruses
Global Handwashing Day and the ongoing spread of COVID-19 is a timely reminder about the importance of handwashing with soap as an effective and affordable way to stay healthy.
COVID-19 as an awakening for hand hygiene access
Globally 3 billion people lack hand hygiene facilities at home and two out of five health care facilities lack hand hygiene at points of care. As the pandemic unfolded around the world, hand sanitizer and handwashing stations became as in-demand…
The World Food Programme wins 2020 Nobel Peace Prize amidst ‘hunger pandemic’ triggered by COVID-19
These global efforts are increasingly urgent as the economic impact of the COVID-19 pandemic continues to put millions of lives at risk from famine and malnutrition.
Will silent reinfections drive the spread of COVID?
People who have had COVID-19 can develop an immune response that normally protects people from recurrent infection. But now that reinfections of COVID-19 have been recorded, what does that mean for our ability to fight the virus?
Immunization continues amid COVID-19
European Commission Civil Protection and Humanitarian Aid Operations (ECHO) humanitarian air bridge made it possible.
Protecting community health workers means protecting communities in the DRC
Preventing and controlling infectious disease is possible with dedication of health workers, multi-stakeholder collaboration and equitable access to vaccines. Africa’s wild polio-free certification, which took decades of collaborative effort, is…
10 things we have now learned about COVID-19
Just over six months since COVID-19 was declared a pandemic, what do we know about this new coronavirus?
What are monoclonal antibodies – and can they treat Covid-19?
For more than 30 years, monoclonal antibodies have transformed the way we treat many diseases. Researchers think they are also one of the most promising treatments for Covid-19. Here's why.
How emergency use authorisations could accelerate access to COVID-19 vaccines
Emergency use procedures are designed to make potentially life-saving medical products available as quickly as possible during health emergencies. A record number have been granted since the arrival of COVID-19 pandemic, but what does this mean…
AVADAR: How digital health fast-tracked Nigeria’s drive to eradicate polio
Polio, a contagious disease caused by the poliomyelitis virus is transmitted primarily when stool from someone infected contaminates foods, drinks or water sources. It invades the nervous system and could, in a matter of hours, lead to complete…
Why I volunteered for a COVID-19 vaccine trial
Vaccines are designed to trigger an immune response to pathogens we’ve never encountered before. But how does it feel to be one of the first humans to encounter a new vaccine? British communications consultant Heather Macdonald-Tait explains what…
How COVID-19 is heightening the economic risks in Gavi-supported countries
In a matter of months, the COVID-19 pandemic has devastated the global economy. Now a new study looks at how this economic shock is impacting sovereign debt levels of Gavi-supported countries.
Q&A with Professor Salim Karim
Africa has not been as hard hit by the COVID-19 pandemic as predicted. Here, we talk to Professor Salim Abdool Karim, the head of South Africa's Ministerial Advisory Committee on COVID-19 to find out why and what the future might hold.
Why the world is at risk without immunisation
Vaccines save lives by protecting children and adults from diseases. COVID-19 pandemic is a clear example of what a world without vaccines could look like. Governments should ensure that delivery of essential services such as vaccines remains a…
How good quality data is vital to saving lives
Throughout the 2016–2020 strategic period, the Vaccine Alliance has worked with countries to improve data quality. From GIS to SMS, new tech and tools aim to reach more people with life-saving immunisation.
How Gavi’s co-financing model works
To bring countries on a trajectory towards financial sustainability, and to empower them to take ownership
of their vaccination programmes, Gavi has pioneered an approach to co-financing and transition.
A Nurse in Uganda is a Trusted Messenger of Hope
Her own healthy baby son is how Ugandan nurse Maureen Wandawa demonstrates the benefits of immunization. Working together to build confidence in, and access to, vaccines for all who need them is one way we can #UniteforHealth to keep us all safer…
Download for life: a mobile app to improve vaccine coverage in Côte d’Ivoire
Gavi's partnership with telecoms provider Orange and the Ministry of Health overcomes barriers to childhood immunisation through tailored, tested technology.
Last updated: 2 May 2024